Impact of serum TRAb level changes on the efficacy of 131I therapy in Graves’ disease: a decision tree prediction model
ObjectivesThis study aims to evaluate the relationship between changes in thyroid stimulating hormone receptor antibody (TRAb) levels before and after treatment and the efficacy of radioactive iodine therapy (RAI) for Graves’ disease (GD). Additionally, a decision tree model was developed to predict...
Saved in:
| Main Authors: | Ziyu Ma, Nan Liu, Yiwang Du, Xuan Wang, Xue Li, Shasha Hou, Zhaowei Meng, Jian Tan, Wei Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1581353/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neonatal Graves’ disease from high maternal TRAB antibody levels despite definitive therapy
by: Dalal S. Ali, et al.
Published: (2025-06-01) -
Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves’ disease: role of TRAbs
by: Sanjay Kalra, et al.
Published: (2024-12-01) -
Combining biomarkers to predict the disease activity of graves’ ophthalmopathy: a combinatory model of the NLR, TRAb and FT4
by: Tongxin Niu, et al.
Published: (2025-06-01) -
The incidence of hypothyroidism following the radioactive iodine treatment of graves' disease and the predictive factors influencing its development
by: Maha Husseni
Published: (2016-01-01) -
Comparing antithyroid drugs vs. radioactive iodine in paediatric Graves’ disease: literature review
by: Akshat Sinha, et al.
Published: (2025-05-01)